| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 713664 | Null | 0.0280810439814509 | 0.014218955 |
| NSC 723397 | Null | 0.0280810439814509 | 0.26517542 |
| NSC 726195 | 2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one | 0.0280810439814509 | 0.22318565 |
| NSC 732568 | 6,8-Dibromo-2-phenyl-3-[5?-amino6?(2??,3??-dichlorophenyl)1, 2,4-triazin-3-yl]quinazolin-4(3H)-one (SPC-IIIBr) | 0.0280810439814509 | 0.1386022 |
| NSC 736122 | 1-(Benzothien-3'-yl)-3,4-dihydronaphthalene-2-acrylic acid ethyl ester | 0.0280810439814509 | 0.10838116 |
| NSC 741440 | 3,3?-furan-2,5-diylbis(5-methoxy-1-methyl-1H-indole) | 0.0280810439814509 | 0.03891661 |
| NSC 743915 | Null | 0.0280810439814509 | 0.027744416 |
| NSC 751902 | 2-4-[5-(3,4-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,7-dimethoxy-1,3-benzothiazole | 0.0280810439814509 | 0.040142646 |
| NSC 764043 | (+)-JQ1 | 0.0280810439814509 | 0.089844587 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0303734648501639 | 0.34286751 |